VivoSim Labs VIVS
NASDAQ VIVS
$0.16 -0.01 (-7.97%)
As of: Oct 22, 2026 · 11:01 AM EDT

VivoSim Labs (VIVS) Return on Equity [ROE] (2013 - 2026)

Updated

VivoSim Labs (VIVS) posted Return on Equity [ROE] of -672.29% for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 442.23 percentage points from -230.07% a year earlier and down 477.14 percentage points from the prior quarter.

Analysis

VivoSim Labs (VIVS) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), VivoSim Labs' Return on Equity [ROE] came in at -239.20%, down 61.98 percentage points from FY2025.

  • Annual Return on Equity [ROE] has declined for four consecutive fiscal years, with a five-year change of -188.12 percentage points (FY2021 to FY2026).
  • In prior fiscal years, VivoSim Labs' Return on Equity [ROE] was -177.22% in FY2025 (-22.09 pp), -155.13% in FY2024 (-79.24 pp), -75.89% in FY2023 (-42.83 pp) and -33.06% in FY2022 (+18.02 pp).
  • The fiscal Q4 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to fiscal Q1 2015.
  • On a year-over-year basis, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -31.06 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q3 2026, with a gain of 417.36 percentage points; the weakest was fiscal Q4 2026, with a drop of 442.23 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -195.15% (Q3 2026), -144.35% (Q2 2026) and -119.69% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Iqvia Holdings 46.37 Bn 38.07 Bn 1.44 Bn 21.80%
2 Medpace Holdings 18.80 Bn 16.87 Bn 201.64 Mn 95.24%
3 Charles River Laboratories International 16.71 Bn 15.91 Bn 363.37 Mn -8.16%
4 Icon 14.67 Bn 11.78 Bn 479.29 Mn 6.40%
5 Fortrea Holdings 2.27 Bn 1.65 Bn 139.20 Mn -16.23%
6 Ginkgo Bioworks Holdings 606.66 Mn -155.42 Mn 18.44 Mn -67.36%
7 Evotec SE 546.94 Mn -1.06 Bn - -
8 Champions Oncology 66.95 Mn 42.60 Mn 7.70 Mn -26.62%
9 MindWalk Holdings 56.59 Mn 20.24 Mn 1.61 Mn -182.13%
10 VivoSim Labs 857,699.93 -16.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -672.29%
Dec 31, 2025 -195.15%
Sep 30, 2025 -144.35%
Jun 30, 2025 -119.69%
Mar 31, 2025 -230.07%
Dec 31, 2024 -612.51%
Sep 30, 2024 -242.54%
Jun 30, 2024 -272.57%
Mar 31, 2024 -300.17%
Dec 31, 2023 -262.88%
Sep 30, 2023 -186.36%
Jun 30, 2023 -133.62%
Mar 31, 2023 -91.87%
Dec 31, 2022 -49.00%
Sep 30, 2022 -45.09%
Jun 30, 2022 -41.91%
Mar 31, 2022 -37.31%
Dec 31, 2021 -37.12%
Sep 30, 2021 -31.17%
Jun 30, 2021 -43.36%
API Access

VivoSim Labs Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VIVS&period=max&api_key=YOUR_API_KEY